Webdisclosure.com

Search

INNATE PHARMA (EPA:IPH) Innate Pharma to present IPH4102 “TELLOMAK” clinical trial design and preclinical PTCL data at the 2019 ICML

Directive transparence : information réglementée

12/06/2019 10:00